Explorer
Advertisement
(Source: ABP CVoter)
DCGI permits emergency use of 2 Covid-19 vaccines in India | Serum-Bharat Biotech
Drugs Controller General of India (DCGI) in a press conference on Sunday has announced that permission has been given for the emergency use of two Covid-19 vaccines in India.
One is 'Covishield' and the other is 'Covaxin' of Serum Institute of India and Bharat Biotech.
Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use, paving the way for their roll-out and administration to millions.
One is 'Covishield' and the other is 'Covaxin' of Serum Institute of India and Bharat Biotech.
Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use, paving the way for their roll-out and administration to millions.
India
Breaking News: BJP's Big Win, Return To Power In Arunachal Pradesh With 33 Seats
ABP-CVoter Exit Poll Result: Political Experts Take On BJP's Seats In Maharashtra | ABP News
ABP-CVoter Exit Poll Result: BJP In Full Swing As Per Post-Poll Survey Predicts | ABP News
Breaking News: Rahul Gandhi Arrives At Congress Headquarters, Watch Report | ABP News
ABP-CVoter Exit Poll Result: Will NDA Retain Its Bastion In Bihar? Post-Poll Survey Predicts | ABP News
View More
Advertisement
Advertisement
Advertisement
Top Headlines
Delhi NCR
India
Election 2024
India
Advertisement